White blood cells are picky about sugar

Schematic of neutrophil response

Neutrophils (shown here in pink) recognize and respond to a particular form of sugar contained on the surface of pathogenic fungi.

Illustration: Tom DiCesare

RELATED MULTIMEDIA

Microscope image of yeast cells

Videos: Ifat Rubin-Bejerano

July 11, 2007

Tags: Fink LabImmune System

CAMBRIDGE, Mass. — Biology textbooks are blunt—neutrophils are mindless killers. These white blood cells patrol the body and guard against infection by bacteria and fungi, identifying and destroying any invaders that cross their path. But new evidence, which may lead to better drugs to fight deadly pathogens, indicates that neutrophils might actually distinguish among their targets.

A scientist in the lab of Whitehead Member Gerald Fink has discovered that neutrophils recognize and respond to a specific form of sugar called beta-1,6-glucan on the surface of fungi. This sugar comprises just a small fraction of the fungal cell wall, much less than another sugar with a slightly different chemical conformation called beta-1,3-glucan. Because the scarce form of the sugar elicits a much stronger reaction from immune cells than the abundant one, it appears that neutrophils can distinguish between two nearly identical chemicals.

“These results show that engulfment and killing by neutrophils varies, depending on cell wall properties of the microbe,” explains Whitehead postdoctoral researcher Ifat Rubin-Bejerano, first author on the paper, which appears online July 11 in the journal Cell Host & Microbe. “We showed that neutrophils respond in a completely different way to slight changes in sugar composition. If we are able to use this unique sugar to excite the immune system, it may help the human body fight infection.”

“Previously, everyone thought that these key cells of the immune system weren't picky and would eat anything that looked foreign,” adds Fink, who is also an MIT professor of biology. “Ifat's work has shown that the cells aren't little Pac-Men, but can discriminate one pathogen from another.”

Rubin-Bejerano had evidence that neutrophils respond to beta-glucan. After coating tiny beads with a variety of substances (including beta-1,3-glucan and beta-1,6-glucan), she exposed them to the neutrophils and was surprised to see a striking difference in their response to the two sugars. The neutrophils quickly engulfed many of the beads coated with beta-1,6-glucan, but only a few of those covered in beta-1,3-glucan.

Previous studies indicated that blood serum (basically blood minus cells) helps neutrophils recognize their enemies, so Rubin-Bejerano decided to look for clues to their response in this mixture. She identified several proteins in serum that bind to beta-1,6-glucan, but not beta-1,3-glucan, and then pinpointed a molecule on the surface of the neutrophil that recognizes these proteins.

To link her experiments back to real fungi, Rubin-Bejerano worked with the pathogen Candida albicans, which is the most common fungus in blood stream infections. She used an enzyme to digest beta-1,6-glucan from the fungal cell wall, leaving the beta-1,3-glucan intact. She then unleashed the neutrophils on these altered cells and observed a 50 percent reduction in the immune response.

Our bodies maintain a fine balance between the immune system and microbes. Antibiotics and antifungals tilt the balance in favor of the immune system by targeting the microbes directly. A substance like beta-1,6-glucan could help tilt this balance further by stimulating immune cells.

Rubin-Bejerano’s work offers hope for combating the growing problem of microbial infections, which can seriously threaten human health—particularly in patients with compromised immune systems. In fact, Rubin-Bejerano co-founded a company called ImmuneXcite to explore this possibility.

This research is supported by the National Institutes of Health.

Written by Alyssa Kneller.

****

Gerald Fink’s primary affiliation is with Whitehead Institute of Biomedical Research, where his laboratory is located and all his research is conducted. He also is a professor of biology at Massachusetts Institute of Technology.

****

Full Citation:

Cell Host & Microbe, July 11, 2007

“ Phagocytosis by human neutrophils is stimulated by a unique fungal cell wall component”

Ifat Rubin-Bejerano(1), Claudia Abeijon(3^), Paula Magnelli(3), Paula Grisafi(1) & Gerald Fink(1,2)

^Present Address: Cummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts

(1) Whitehead Institute for Biomedical Research, Cambridge, Massachusetts
(2) Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts
(3) Department of Molecular and Cell Biology, Goldman School of Dental Medicine, Boston, Massachusetts

CONTACT

Communications and Public Affairs
Phone: 617-258-6851
Email: newsroom@wi.mit.edu


RELATED LINK

Cloaking device helps pathogens evade the immune system

Study yields insights into fungi—and beer

Whitehead Institute is a world-renowned non-profit research institution dedicated to improving human health through basic biomedical research.
Wholly independent in its governance, finances, and research programs, Whitehead shares a close affiliation with Massachusetts Institute of Technology
through its faculty, who hold joint MIT appointments.

© Whitehead Institute for Biomedical Research         Nine Cambridge Center    Cambridge, MA 02142